US 10517864
Sustained-release buprenorphine solutions
granted A61KA61K31/485A61K47/10
Quick answer
US patent 10517864 (Sustained-release buprenorphine solutions) held by Indivior UK Limited expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Indivior UK Limited
- Grant date
- Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/485, A61K47/10, A61K47/22, A61K9/0019